These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32393810)

  • 1. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
    Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
    Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.
    Wang LL; Zong ZH; Liu Y; Guan X; Chen S; Zhao Y
    J Cell Mol Med; 2019 Dec; 23(12):8472-8481. PubMed ID: 31639291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.
    Lu T; Wu B; Yu Y; Zhu W; Zhang S; Zhang Y; Guo J; Deng N
    Cancer Sci; 2018 Jul; 109(7):2221-2234. PubMed ID: 29737581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
    Fang Y; Sun B; Wang J; Wang Y
    Gene; 2019 May; 699():37-42. PubMed ID: 30851425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway.
    Tang W; Huang C; Jiang B; Lin J; Lu Y
    J Microbiol Biotechnol; 2024 Jul; 34(7):1433-1442. PubMed ID: 38955795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
    Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-mediated lncRNA SNHG11 regulates angiogenesis in pancreatic carcinoma through miR-324-3p/VEGFA axis.
    Fang X; Cai Y; Xu Y; Zhang H
    Cell Biol Int; 2022 Jan; 46(1):106-117. PubMed ID: 34519129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203/VEGFA Axis.
    Chen LJ; Yuan MX; Ji CY; Zhang YB; Peng YM; Zhang T; Gao HQ; Sheng XY; Liu ZY; Xie WX; Yin Q
    Pathobiology; 2020; 87(3):161-170. PubMed ID: 32182608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.
    Sun SL; Shu YG; Tao MY
    Mol Cell Biochem; 2020 May; 468(1-2):69-82. PubMed ID: 32236863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
    Li Y; Zhang J; Zhang L; Si M; Yin H; Li J
    Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.
    Lin X; Yang F; Qi X; Li Q; Wang D; Yi T; Yin R; Zhao X; Zhong X; Bian C
    Mol Carcinog; 2019 Dec; 58(12):2286-2296. PubMed ID: 31545000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.